ProfileGDS5678 / 1422272_at
TitleAnti-VEGF and Anti-Notch treatment effect on U87 glioblastoma xenograft tumors [Mouse430_2]
OrganismMus musculus


control bevacizumab dibenzazepine GSM967852 GSM967853 GSM967854 GSM967855 GSM967856 GSM967862 GSM967863 GSM967864 GSM967865 GSM967857 GSM967858 GSM967859 GSM967860 GSM967861 1% 1% 1% 2% 1% 1% 1% 1% 1% 1% 1% 1% 2% 1% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM967852U87-EV human glioblastoma xenograft - Control 11.795361
GSM967853U87-EV human glioblastoma xenograft - Control 21.798991
GSM967854U87-EV human glioblastoma xenograft - Control 31.803351
GSM967855U87-EV human glioblastoma xenograft - Control 41.775122
GSM967856U87-EV human glioblastoma xenograft - Control 51.761631
GSM967862U87-EV human glioblastoma xenograft - Bevacizumab treated 11.820721
GSM967863U87-EV human glioblastoma xenograft - Bevacizumab treated 21.797511
GSM967864U87-EV human glioblastoma xenograft - Bevacizumab treated 31.782451
GSM967865U87-EV human glioblastoma xenograft - Bevacizumab treated 41.782761
GSM967857U87-EV human glioblastoma xenograft - dibenzazepine treated 11.791841
GSM967858U87-EV human glioblastoma xenograft - dibenzazepine treated 21.534671
GSM967859U87-EV human glioblastoma xenograft - dibenzazepine treated 31.781691
GSM967860U87-EV human glioblastoma xenograft - dibenzazepine treated 41.843562
GSM967861U87-EV human glioblastoma xenograft - dibenzazepine treated 51.789481